
Pharmacist Strikes it Rich with AI Tool, $25m ARR at 40% EBITDA | TJM Labs CEO Jonathan Adly
ARR (2026)
$25M
EBITDA Margin (2026)
40%
Pharmacy Customers (2026)
450
Avg Contract Value (2026)
$45,000 per bot per year
Interviewed published
Nathan Latka gets revenue, growth, and funding data straight from the founders. Browse 2,193 interviews with SaaS CEOs.
Find more interviews on Spotify or Apple Podcasts.
























Page 1 of 92
Subscribe to the SaaS Interviews podcast on your favorite app.
Sign up to access all features
Sign up with GoogleSign up with LinkedInAlready have an account? Log in
GetLatka is trusted by 200k+ founders, researchers, and marketers.
No contracts, cancel at any time